Optometry Australia’s infection control guidelines 2020

Hart, Kerryn M; Stapleton, Fiona; Carnt, Nicole; Arundel, Luke; Lian, Ka‐Yee

doi:10.1080/08164622.2021.1887704

Cited by 2 publications

(2 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Remote monitoring devices and home-based testing kits are projected to grow more advanced, allowing patients to self-assess their eye health. This can help in the early diagnosis of problems and fast action, which is especially important for people who may have difficulty accessing in-person treatment [ 115 ]. Horton et al set out guidelines for diabetic retinopathy screening and this has been useful in standardizing telediagnostics [ 116 ].…”

Section: The Future Of Ophthalmology Conditioned By This Global Pande...mentioning

confidence: 99%

Considerations of COVID-19 in Ophthalmology

Salvetat,

Musa,

Pellegrini

et al. 2023

Microorganisms

View full text Add to dashboard Cite

Since its emergence in early 2020, the SARS-CoV-2 infection has had a significant impact on the entire eye care system. Ophthalmologists have been categorized as a high-risk group for contracting the virus due to the belief that the eye may be a site of inoculation and transmission of the SARS-CoV-2 infection. As a result, clinical ophthalmologists, optometrists, and eyecare professionals have had to familiarize themselves with the ocular manifestations of COVID-19, as well as its treatments and vaccines. The implementation of measures to prevent the transmission of the virus, such as restrictions, lockdowns, telemedicine, and artificial intelligence (AI), have led to substantial and potentially irreversible changes in routine clinical practice, education, and research. This has resulted in the emergence of a new mode of managing patients in a routine clinical setting. This brief review aims to provide an overview of various aspects of COVID-19 in ophthalmology, including the ocular manifestations related to the disease, the modes of transmission of SARS-CoV-2 infection, precautions taken in ophthalmic practice to prevent the spread of the virus, drugs, and vaccines used in the treatment of COVID-19, the impact of the pandemic on patients, clinicians, and the eye care system as a whole, and the future of ophthalmology conditioned by this global pandemic experience.

show abstract

Section: The Future Of Ophthalmology Conditioned By This Global Pande...mentioning

confidence: 99%

Considerations of COVID-19 in Ophthalmology

Salvetat,

Musa,

Pellegrini

et al. 2023

Microorganisms

View full text Add to dashboard Cite

show abstract

“…With governments around the world attempting to change the behaviour of their citizens to minimise the risk of virus transmission, this issue includes a timely update to the Infection Control Guidelines for Optometrists and how practitioners are expected to contribute to the prevention of infection transmission as part of their clinical practice. Hart et al 15 Dang et al 16 summarise existing evidence for use of povidone iodine for adenovirus in the eye. Phu et al provide a contemporary perspective on the somewhat dated National Health and Medical Research Council clinical care guidelines for glaucoma and propose a new management paradigm for early-stage primary open-angle glaucoma favouring an individualised, preservative-free and/or selective laser trabeculoplasty therapy over the more traditional approach.…”

mentioning

confidence: 99%

Ocular therapeutics: from special interest to standard care

Hui

Jalbert

2021

Clinical and Experimental Optometry

View full text Add to dashboard Cite

Optometry Australia’s infection control guidelines 2020

Cited by 2 publications

References 25 publications

Considerations of COVID-19 in Ophthalmology

Considerations of COVID-19 in Ophthalmology

Ocular therapeutics: from special interest to standard care

Contact Info

Product

Resources

About